Comparative Value of Cholinesterase Inhibitors and Memantine in Persons With Moderate-To-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis
Faculty Publications
Part of the Medicine and Health Sciences Commons
Part of the Medicine and Health Sciences Commons